SCHEMBL2170025

SCHEMBL2170025

C[Si](C)(C)c1ccc(OS(=O)(=O)C(F)(F)F)cc1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 2/20 0.45
CXCR1 P25024 1/20 0.44
HSD11B1 P28845 1/20 0.41
CA2 P00918 6/20 0.41
CA1 P00915 5/20 0.41
CA9 Q16790 5/20 0.40
DRD2 P14416 3/20 0.40
DRD3 P35462 3/20 0.40
DRD4 P21917 2/20 0.40
DRD1 P21728 1/20 0.40
DRD5 P21918 1/20 0.40
NR1H2 P55055 1/20 0.38
NR1H3 Q13133 1/20 0.38
CHRM1 P11229 1/20 0.37
KIF11 P52732 1/20 0.37
HTR1D P28221 4/20 0.37
HTR1A P08908 3/20 0.37
HTR1B P28222 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL576035 0.85 CA2 (0.50) CXCR2CXCR1HSD11B1CA2CA1
SCHEMBL28726740 0.82 CXCR2 (0.44) CXCR2CXCR1HSD11B1CA2CA1
SCHEMBL26549561 0.80 HSD11B1 (0.43) HSD11B1CA2CA1CA9DRD2
SCHEMBL2750188 0.79 CA2 (0.57) CXCR2CXCR1HSD11B1CA2CA1
SCHEMBL1997269 0.79 CA1 (0.57) CXCR2CXCR1HSD11B1CA2CA1
SCHEMBL1713465 0.79 KIF11 (0.55) CXCR2CXCR1HSD11B1CA2CA1
SCHEMBL5179823 0.79 PTPN1 (0.53) CXCR2CXCR1HSD11B1CA2CA1
Iodide SCHEMBL1859836 0.78 CA1 (0.55) CXCR2CXCR1HSD11B1CA2CA1
Hydrogen Sulfide SCHEMBL6248782 0.78 CA2 (0.55) CXCR2CXCR1HSD11B1CA2CA1
Hydrogen Sulfide SCHEMBL5082548 0.78 CA1 (0.55) CXCR2CXCR1HSD11B1CA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110105259-B Method for removing sulfinyl in heteroarene compound 浙江师范大学 2020-08-18 CN claimed
EP-3013787-A1 TRANSITION-METAL-FREE N-ARYLATION OF TERTIARY AMINES USING ARYNES Council of Scientific & Industrial Research (IN) 2016-05-04 EP claimed
WO-2015128878-A1 NOVEL BENZOXAPHOSPHOLE COMPOUNDS AND A PROCESS FOR PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-09-03 WO claimed
WO-2014207761-A1 TRANSITION-METAL-FREE N-ARYLATION OF TERTIARY AMINES USING ARYNES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2014-12-31 WO claimed
CN-111548269-B Preparation method of diaryl methane structural compound 兰州大学 2023-10-27 CN disclosed
CN-115448941-A Preparation method of allyl substituted aryl organosilicon compound 青海师范大学 2022-12-09 CN disclosed
CN-110015942-B Method for directly synthesizing biaryl compound without metal catalysis 浙江师范大学 2021-12-24 CN disclosed
CN-111548269-A Preparation method of diarylmethane structure compound 兰州大学 2020-08-18 CN disclosed
EP-3013787-A1 TRANSITION-METAL-FREE N-ARYLATION OF TERTIARY AMINES USING ARYNES Council of Scientific & Industrial Research (IN) 2016-05-04 EP disclosed
WO-2014207761-A1 TRANSITION-METAL-FREE N-ARYLATION OF TERTIARY AMINES USING ARYNES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2014-12-31 WO disclosed
EP-2346863-A2 N-SULFONAMIDO POLYCYCLIC PYRAZOLYL COMPOUNDS Elan Pharmaceuticals Inc. (US) 2011-07-27 EP disclosed
WO-2010028213-A2 N-SULFONAMIDO POLYCYCLIC PYRAZOLYL COMPOUNDS ELAN PHARMACEUTICALS, INC. (US) 2010-03-11 WO disclosed
EP-1979324-A2 NOVEL 2-AMINO-IMIDAZOLE-4-ONE COMPOUNDS AND THEIR USE IN THE MANUFACTURE OF A MEDICAMENT TO BE USED IN THE TREATMENT OF COGNITIVE IMPAIRMENT, ALZHEIMER'S DISEASE, NEURODEGENERATION AND DEMENTIA Astra Zeneca AB (SE) 2008-10-15 EP disclosed
WO-2007058602-A2 NOVEL 2-AMINO-IMIDAZOLE-4-ONE COMPOUNDS AND THEIR USE IN THE MANUFACTURE OF A MEDICAMENT TO BE USED IN THE TREATMENT OF COGNITIVE IMPAIRMENT, ALZHEIMER’S DISEASE, NEURODEGENERATION AND DEMENTIA. ASTRAZENECA AB (SE) 2007-05-24 WO disclosed